Nexus Biopharma

Nexus BioPharma is developing a treatment for obesity and the symptoms of pre-diabetes. Nexus’ first product is a small molecule drug that activates cellular regulatory pathways that regulate obesity/diabetes to increase energy expenditure.

Focus area
Cardiovascular and Metabolism
Commencement date
02/01/2017